SE453088B - 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl-)butyl)-1-piperazinyl)pyrimidiner, deras framstellning och farmaceutiska kompositioner - Google Patents
2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl-)butyl)-1-piperazinyl)pyrimidiner, deras framstellning och farmaceutiska kompositionerInfo
- Publication number
- SE453088B SE453088B SE8207425A SE8207425A SE453088B SE 453088 B SE453088 B SE 453088B SE 8207425 A SE8207425 A SE 8207425A SE 8207425 A SE8207425 A SE 8207425A SE 453088 B SE453088 B SE 453088B
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- compound
- acid addition
- piperazinyl
- pyrimidinyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
- C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/56—One oxygen atom and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/334,688 US4423049A (en) | 1981-12-28 | 1981-12-28 | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8207425D0 SE8207425D0 (sv) | 1982-12-27 |
SE8207425L SE8207425L (sv) | 1983-08-12 |
SE453088B true SE453088B (sv) | 1988-01-11 |
Family
ID=23308351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8207425A SE453088B (sv) | 1981-12-28 | 1982-12-27 | 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl-)butyl)-1-piperazinyl)pyrimidiner, deras framstellning och farmaceutiska kompositioner |
Country Status (26)
Country | Link |
---|---|
US (1) | US4423049A (de) |
JP (2) | JPS58118582A (de) |
KR (1) | KR870001045B1 (de) |
AT (1) | AT382373B (de) |
AU (1) | AU555797B2 (de) |
BE (1) | BE895504A (de) |
CA (1) | CA1244426A (de) |
CH (1) | CH656383A5 (de) |
CY (1) | CY1379A (de) |
DE (1) | DE3248160C2 (de) |
DK (1) | DK162389C (de) |
ES (2) | ES518510A0 (de) |
FI (1) | FI70891C (de) |
FR (1) | FR2518993B1 (de) |
GB (1) | GB2114122B (de) |
GR (1) | GR77045B (de) |
HK (1) | HK5288A (de) |
IE (1) | IE54619B1 (de) |
IT (1) | IT1158039B (de) |
KE (1) | KE3709A (de) |
LU (1) | LU84561A1 (de) |
NL (1) | NL193283C (de) |
PT (1) | PT76036B (de) |
SE (1) | SE453088B (de) |
SG (1) | SG29787G (de) |
ZA (1) | ZA828549B (de) |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
US4581357A (en) * | 1983-02-07 | 1986-04-08 | Mead Johnson & Company | Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound |
US5187276A (en) * | 1983-06-18 | 1993-02-16 | Troponwerke Gmbh & Co. Kg. | 2-pyrimidinyl-1-piperazine derivatives |
DE3321969A1 (de) * | 1983-06-18 | 1984-12-20 | Troponwerke GmbH & Co KG, 5000 Köln | 2-pyrimidinyl-1-piperazin-derivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
CA1250291A (en) * | 1984-07-23 | 1989-02-21 | Bristol-Myers Company | Psychogeriatric 1-(2-pyrimidinyl)-piperazinyl derivatives of 1-pyrrolidin-2-ones |
US4668687A (en) * | 1984-07-23 | 1987-05-26 | Bristol-Myers Company | Psychogeriatric 1-(2-pyrimidinyl)piperazinyl derivatives of 1-pyrrolidin-2-ones |
HUT43600A (en) * | 1985-06-22 | 1987-11-30 | Sandoz Ag | Process for production of new thiazole derivatives and medical compound containing those |
NZ216720A (en) * | 1985-07-08 | 1990-09-26 | Bristol Myers Co | Diazinylpiperidine derivatives and pharmaceutical compositions |
US4826843A (en) * | 1985-07-08 | 1989-05-02 | Bristol-Myers | Cerebral function enhancing diazinylpiperidine derivatives |
US4777254A (en) * | 1986-12-02 | 1988-10-11 | American Home Products Corp. | Cyclic imides as H1 -antagonists |
US4771053A (en) * | 1987-03-02 | 1988-09-13 | Bristol-Myers Company | Method for alleviation of primary depressive disorders |
US4782060A (en) * | 1987-07-29 | 1988-11-01 | Bristol-Myers Company | Gepirone for alleviation of panic disorders |
US4880930A (en) * | 1987-11-30 | 1989-11-14 | New James S | Psychotropic acyclic amide derivatives |
US5116970A (en) * | 1988-02-18 | 1992-05-26 | New James S | Psychotropic heterobicycloalkylpiperazine derivatives: 2. fused pyridazinones |
US5001130A (en) * | 1988-02-18 | 1991-03-19 | Bristol-Myers Company | Psychotropic heterobicycloalkylpiperazine derivatives |
US4780466A (en) * | 1988-03-17 | 1988-10-25 | Hoechst-Roussel Pharmaceuticals, Inc. | Arylpiperazinylalkoxy derivatives of cyclic imides |
US5242911A (en) * | 1988-06-17 | 1993-09-07 | Pfizer Inc. | Bridged bicyclic imides as anxiolytics and antidepressants |
US5077295A (en) * | 1988-09-16 | 1991-12-31 | Pfizer Inc. | Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides |
FR2654934B1 (fr) * | 1989-11-29 | 1994-09-30 | Midy Spa | Utilisation de derive [4-(2-pyrimidinyl)-1-piperazinyl] butyliques pour la preparation de medicaments destines a combattre les troubles de la motricite intestinale. |
US5098904A (en) * | 1990-06-27 | 1992-03-24 | Bristol-Myers Squibb Company | Cerebral function enhancing pyrimidinyl derivatives |
WO1992010200A1 (en) * | 1990-12-14 | 1992-06-25 | New York University | Functional interactions between glial s-100b and central nervous system serotonergic neurons |
US5824680A (en) * | 1991-08-31 | 1998-10-20 | Bayer Aktiengesellschaft | Ipsapirone for the treatment of alzheimer's disease by improving memory |
DE4135551A1 (de) * | 1991-08-31 | 1993-03-04 | Schering Ag | Verwendung von antagonisten oder partiellen agonisten am 5-ht1a-rezeptor zur behandlung und praevention von kognitiven stoerungen |
GB9223153D0 (en) * | 1992-11-05 | 1992-12-16 | Wyeth John & Brother Ltd | Piperazine derivatives |
FR2701260B1 (fr) * | 1993-02-05 | 1995-05-05 | Esteve Labor Dr | Dérivés de 2-[4-(4-azolylbutyl)-1-pipérazinyl]-5-hydroxypyrimidine, leur préparation et leur application en tant que médicaments. |
US5338738A (en) * | 1993-04-19 | 1994-08-16 | Bristol-Myers Squibb Company | Cerebral function enhancers: acyclic amide derivatives of pyrimidinylpiperidines |
FR2705098B1 (fr) * | 1993-05-10 | 1995-08-04 | Esteve Labor Dr | Procédé de préparation de 2-{4-[4-(chloro-1-pyrazolyl)butyl]1-pipérazinyl}pyrimidine (Lesopitron) . |
US5538985A (en) * | 1994-01-27 | 1996-07-23 | Mitsui Toatsu Chemicals, Inc. | Pyrrolidinone derivatives |
CA2146593A1 (en) * | 1994-05-05 | 1995-11-06 | Jack Melton | Large-scale process for azapirone synthesis |
US5521313A (en) * | 1994-05-05 | 1996-05-28 | Bristol-Myers Squibb Company | Process for preparing certain azapirones |
US5478572A (en) * | 1994-09-06 | 1995-12-26 | Bristol-Myers Squibb Co. | Gepirone dosage form |
US6312717B1 (en) | 1998-07-07 | 2001-11-06 | Bristol-Myers Squibb Company | Method for treatment of anxiety and depression |
WO2000006163A1 (en) * | 1998-07-30 | 2000-02-10 | Bristol-Myers Squibb Company | Improved method for treatment of sleep-related respiratory disorders |
US6566361B2 (en) | 1999-06-30 | 2003-05-20 | Laboratories, Upsa | Azapirone pain treatment |
US6534507B1 (en) * | 1999-12-20 | 2003-03-18 | Fabre-Kramer Pharmaceuticals, Inc. | Methods for treating psychological disorders using bioactive metabolites of gepirone |
CN100367965C (zh) * | 1999-12-20 | 2008-02-13 | 法布瑞-克雷默制药有限公司 | 吉吡隆代谢物在制备改善哺乳动物不良心理状态的组合物上的应用 |
RU2268725C2 (ru) * | 2000-01-19 | 2006-01-27 | Акцо Нобель Н.В. | Комбинация лекарственных препаратов, включающая миртазапин, для лечения депрессии и связанных расстройств |
AU2001295478A1 (en) * | 2000-08-22 | 2002-03-04 | Akzo Nobel N.V. | Active metabolite of gepirone |
JP2004517081A (ja) * | 2000-11-29 | 2004-06-10 | イーライ・リリー・アンド・カンパニー | 1−(2−m−メタンスルホンアミドフェニルエチル)−4−(m−トリフルオロメチルフェニル)ピペラジンならびにその医薬的に許容しうる塩および溶媒和物 |
US20040002500A1 (en) * | 2002-06-28 | 2004-01-01 | Fabre Kramer Pharmaceutical, Inc. | Methods for treating attention deficit disorder |
US20040147581A1 (en) * | 2002-11-18 | 2004-07-29 | Pharmacia Corporation | Method of using a Cox-2 inhibitor and a 5-HT1A receptor modulator as a combination therapy |
CN101693697A (zh) * | 2003-07-30 | 2010-04-14 | 泽农医药公司 | 哌嗪衍生物和它们作为治疗剂的用途 |
EP1689721B1 (de) * | 2003-11-26 | 2010-07-14 | Pfizer Products Inc. | Aminopyrazolderivate als gsk-3-inhibitoren |
US20060099267A1 (en) * | 2004-11-05 | 2006-05-11 | Fabre-Kramer Pharmaceuticals, Inc. | High-dosage extended-release formulation of gepirone |
BRPI0419179A (pt) * | 2004-11-05 | 2007-12-18 | Fabre Kramer Pharmaceuticals I | formulação de alta dosagem de liberação prolongada de gepirona |
PT2159226T (pt) * | 2007-03-29 | 2016-12-16 | Joint-Stock Company Obninsk Chemical Pharmaceutical Company | Agente anti-histamínico e antialérgico e um método para a produção do mesmo |
WO2011030139A1 (en) * | 2009-09-11 | 2011-03-17 | Astrazeneca Ab | 4- (pyrimidin-2-yl) -piperazine and 4- (pyrimidin-2-yl) -piperidine derivatives as gpr119 modulators |
IT201900000657A1 (it) | 2019-01-16 | 2020-07-16 | Procos Spa | Processo per la sintesi di gepirone |
GB202014736D0 (en) * | 2020-09-18 | 2020-11-04 | Imperial College Innovations Ltd | Novel compounds and their use in therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3398151A (en) * | 1966-02-01 | 1968-08-20 | Mead Johnson & Co | Azaspirodecanediones and azaspiroundecanediones |
BE759371A (fr) * | 1969-11-24 | 1971-05-24 | Bristol Myers Co | Azaspirodecanediones heterocycliques et procedes pour leur preparation |
US3976776A (en) * | 1972-12-06 | 1976-08-24 | Mead Johnson & Company | Tranquilizer process employing N-(heteroarcyclic)piperazinylalkylazaspiroalkanediones |
US4182763A (en) * | 1978-05-22 | 1980-01-08 | Mead Johnson & Company | Buspirone anti-anxiety method |
IL57569A0 (en) | 1978-06-20 | 1979-10-31 | Synthelabo | Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them |
US4423049A (en) * | 1981-12-28 | 1983-12-27 | Mead Johnson & Company | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyrimidines |
-
1981
- 1981-12-28 US US06/334,688 patent/US4423049A/en not_active Expired - Lifetime
-
1982
- 1982-11-19 ZA ZA828549A patent/ZA828549B/xx unknown
- 1982-11-22 CA CA000416088A patent/CA1244426A/en not_active Expired
- 1982-12-02 AU AU91083/82A patent/AU555797B2/en not_active Expired
- 1982-12-08 KR KR8205503A patent/KR870001045B1/ko active
- 1982-12-08 GR GR70021A patent/GR77045B/el unknown
- 1982-12-22 IT IT49719/82A patent/IT1158039B/it active
- 1982-12-23 ES ES518510A patent/ES518510A0/es active Granted
- 1982-12-23 DK DK573182A patent/DK162389C/da not_active IP Right Cessation
- 1982-12-23 JP JP57225098A patent/JPS58118582A/ja active Granted
- 1982-12-23 IE IE3067/82A patent/IE54619B1/en not_active IP Right Cessation
- 1982-12-23 GB GB08236593A patent/GB2114122B/en not_active Expired
- 1982-12-23 FI FI824442A patent/FI70891C/fi not_active IP Right Cessation
- 1982-12-23 NL NL8204970A patent/NL193283C/nl not_active IP Right Cessation
- 1982-12-23 CY CY137982A patent/CY1379A/xx unknown
- 1982-12-24 FR FR8221750A patent/FR2518993B1/fr not_active Expired
- 1982-12-27 PT PT76036A patent/PT76036B/pt unknown
- 1982-12-27 DE DE3248160A patent/DE3248160C2/de not_active Expired - Lifetime
- 1982-12-27 SE SE8207425A patent/SE453088B/sv not_active IP Right Cessation
- 1982-12-28 AT AT0469882A patent/AT382373B/de not_active IP Right Cessation
- 1982-12-28 CH CH7594/82A patent/CH656383A5/de not_active IP Right Cessation
- 1982-12-28 BE BE0/209826A patent/BE895504A/fr not_active IP Right Cessation
- 1982-12-29 LU LU84561A patent/LU84561A1/fr unknown
-
1983
- 1983-08-12 ES ES524945A patent/ES524945A0/es active Granted
-
1987
- 1987-03-27 SG SG297/87A patent/SG29787G/en unknown
- 1987-03-31 KE KE3709A patent/KE3709A/xx unknown
-
1988
- 1988-01-21 HK HK52/88A patent/HK5288A/xx not_active IP Right Cessation
-
1991
- 1991-03-29 JP JP3216768A patent/JPH06293753A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE453088B (sv) | 2-(4-((4,4-dialkyl-2,6-piperidindion-1-yl-)butyl)-1-piperazinyl)pyrimidiner, deras framstellning och farmaceutiska kompositioner | |
DK171990B1 (da) | 1-Heteroaryl-4-((2,5-pyrrolidindion-1-yl)-alkyl)piperazin-derivater, fremgangsmåder til deres fremstilling samt farmaceutiske midler omfattende disse derivater | |
RU2096411C1 (ru) | Производные бензимидазолона, смеси их изомеров или их кислотно-аддитивные соли в качестве антагониста рецептора 5-ht*00i*00a и 5-нт*002 | |
RU2061695C1 (ru) | Способ получения арилпиперазинил-гетероциклических соединений или их фармацевтически приемлемой кислотно-аддитивной соли | |
FI88504B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2h)-ftalazinonderivat | |
Wyatt et al. | Benzophenone derivatives: a novel series of potent and selective inhibitors of human immunodeficiency virus type 1 reverse transcriptase | |
US4361565A (en) | 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines | |
SE442636B (sv) | N-((4-(3-substituerad pyridyl)piperazino)butyl)azaspirodekandioner, forfarande for deras framstellning och farmaceutisk komposition derav | |
GB2120670A (en) | Piperazine derivatives | |
US4492696A (en) | Piperazine and homopiperazine compounds | |
JPH0223548B2 (de) | ||
US4581357A (en) | Antipsychotic 5-fluoro-pyrimidin-2-yl piperazine compound | |
JPH0319233B2 (de) | ||
JPH0631231B2 (ja) | 抗精神病性4―[4―(3―ベンズイソチアゾリル)―1―ピペラジニルブチル架橋二環式イミド | |
HU197567B (en) | Process for producing heterocyclic carbonyl derivatives of 4-(2-pyrimidinyl)-1-piperazine and pharmaceuticals comprising same as active ingredient | |
GB2094801A (en) | Azaspiroalkanes | |
CS258133B2 (cs) | Způsob výroby l-heteroaryl-4-[(2,5-pyrrolidindion-l-yl)alkyl]- piperazinových derivátů |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8207425-3 Format of ref document f/p: F |
|
NUG | Patent has lapsed |